Quiver Bioscience secures a $2.15 million SBIR grant to enhance its CNS genetic medicine platform and develop AI/ML predictors of drug safety.
Amount Raised
$2.15 Million
Round Type
Grant
CambridgeBiotechnologyHealth CareArtificial IntelligenceDescription
Quiver Bioscience announced receipt of a $2.15 million Phase II SBIR grant from the NIH. The funding will facilitate the development of a platform for predicting the safety of CNS-targeted ASO therapeutics. This grant aims to optimize the testing processes for these innovative treatments. Quiver's approach combines advanced human neuronal models with AI/ML capabilities.
Quick answer
Quiver Bioscience raised $2.15 Million in a Grant round, dated July 1, 2025. Quiver Bioscience is based in Cambridge, Massachusetts, United States.
- How much did Quiver Bioscience raise?
- Quiver Bioscience raised $2.15 Million in a Grant round on July 1, 2025.
- What does Quiver Bioscience do?
- Quiver Bioscience is a technology-driven company established to create transformational medicines for the brain while simultaneously uncovering new biology and novel, effective drug targets.
- Where is Quiver Bioscience based and how big is it?
- Quiver Bioscience is based in Cambridge, Massachusetts, United States. Fundz records about 43 employees.
- Who are the decision-makers at Quiver Bioscience?
- Fundz holds 5 contacts at Quiver Bioscience, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Quiver Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Citizen Health raised $30M (Series A) on August 15, 2025.
- Moberg Analytics raised an undisclosed amount (Seed) on July 29, 2025.
- pRxEngage raised an undisclosed amount (Seed) on July 29, 2025.
- JotPsych raised $5M (Seed) on July 29, 2025.
- Positron raised $52M (Series A) on July 28, 2025.
- Plexision raised $365K (Funding Round) on July 24, 2025.
Who to call at Quiver Bioscience, and when
A new round usually means Quiver Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Quiver Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quiver Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quiver Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Quiver Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Quiver Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.